Author:
Wang Hui,Shi Meng-Jie,Hu Zhang-Qin,Miao Lin,Cai He-Shi,Zhang Rui-Peng
Abstract
AbstractLower limb ischemia–reperfusion is a common pathological process during clinical surgery. Because lower limb ischemia–reperfusion usually aggravates ischemia-induced skeletal muscle tissue injury after lower limb ischemia–reperfusion, it also causes remote organ heart, intestine, liver, lung and other injuries, and there is no effective clinical treatment for lower limb ischemia–reperfusion injury, so it is urgent to study its injury mechanism. In this study, the rat model of lower limb ischemia–reperfusion was established by clamping the femoral artery with microarterial clips, and the wall destruction such as intimal injury, cell edema, collagen degeneration, neutrophil infiltration, and elastic fiberboard injury of the femoral artery wall was detected. The expression of inflammatory factors was detected by immunohistochemistry. miR-206 preconditioning was used to observe the expression of inflammatory factors, redox status and apoptosis in the vascular wall of rats after acute limb ischemia–reperfusion. Our findings suggest that vascular endothelial cell edema increases, wall thickening, neutrophil infiltration, and elastic fiber layer damage during IRI. Inflammatory factor expression was increased in femoral artery tissue, and miR-206 expression levels were significantly down-regulated. Further studies have found that miR-206 attenuates lower limb IRI by regulating the effects of phase inflammatory factors. In this study, we investigated the effect of miR-206 on inflammatory factors and its possible role in the development of lower limb IRI, providing new research ideas for the regulatory mechanism of lower limb IRI, and providing a certain theoretical basis for the treatment of lower limb ischemia–reperfusion injury after surgery or endovascular intervention.
Funder
Shaanxi Province Science and Technology Project
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Li, X. et al. Targeting ferroptosis: Pathological mechanism and treatment of ischemia-reperfusion injury. Oxid. Med. Cell. Longev. 2021, 1587922 (2021).
2. Utsunomiya, M. Endovascular therapy for acute limb ischemia. J. Atheroscler. Thromb. 28(11), 1126–1127 (2021).
3. King, E. G. & Farber, A. What is the best treatment for acute limb ischemia?. Adv. Surg. 56(1), 287–304 (2022).
4. Cearra, I. et al. Effects of folinic acid administration on lower limb ischemia/reperfusion injury in rats. Antioxidants (Basel, Switzerland) 10(12), 1887 (2021).
5. Apichartpiyakul, P., Shinlapawittayatorn, K., Rerkasem, K., Chattipakorn, S. C. & Chattipakorn, N. Mechanisms and interventions on acute lower limb ischemia/reperfusion injury: A review and insights from cell to clinical investigations. Ann. Vasc. Surg. 86, 452–481 (2022).